GH
WST icon

GAM Holding’s West Pharmaceutical WST Stock Holding History

GAM Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,886
Closed -$621K – 170
2024
Q2 		$621K Sell
1,886
-1
-0.1% -$353 0.05% 142
2024
Q1 		$747K Sell
1,887
-2
-0.1% -$740 0.05% 145
2023
Q4 		$665K Buy
+1,889
New +$669K 0.05% 147
2020
Q1 		– Sell
-1,784
Closed -$268K – 545
2019
Q4 		$268K Sell
1,784
-2,487
-58% -$362K 0.01% 461
2019
Q3 		$606K Buy
+4,271
New +$588K 0.03% 531

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GAM Holding's WST Position: Q3 2024 in Review

GAM Holding sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 1,886 shares — an estimated $621K sold.

GAM Holding first reported a position in WST in Q3 2019 and held it in 5 quarters. The position peaked at $747K in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • GAM Holding reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • GAM Holding sold 1,886 West Pharmaceutical shares in Q3 2024, an estimated $621K.
  • GAM Holding first reported a position in West Pharmaceutical in Q3 2019 and held it in 5 quarters.
  • GAM Holding's West Pharmaceutical position peaked at $747K in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on GAM Holding's 13F filing for Q3 2024, filed 22 Oct 2024.